Revolution Medicines

$40.32
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.23 (+3.15%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell RVMD and other stocks, options, and ETFs commission-free!

About RVMD

Revolution Medicines, Inc. Common Stock, also called Revolution Medicines, is a clinical-stage precision oncology company focused on developing novel targeted therapies.

CEO
Mark A. Goldsmith
Employees
125
Headquarters
Redwood City, California
Founded
2015
Market Cap
2.85B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
514.71K
High Today
$40.86
Low Today
$39.27
Open Price
$40.00
Volume
315.95K
52 Week High
$56.18
52 Week Low
$21.17

RVMD Earnings

-$0.74
-$0.49
-$0.25
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 9, Pre-Market

You May Also Like

OUSM
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure